Older adult exercise has no single inflammation winner
In short
Across 82 studies of 6,493 older adults, aerobic training led IL-6 and TNF-α network rankings; resistance led CRP. All outcomes had very low GRADE certainty, so these rankings cannot establish a superior training choice.
A systematic review published on October 14, 2026 pooled 82 studies involving 6,493 adults aged at least 60, with a mean age of 71.04 years. Across exercise interventions, the standardized mean differences were −0.31 for IL-6, −0.44 for CRP and −0.40 for TNF-α, all in the direction of lower levels. These are standardized effect sizes, not percentage reductions. A CRP SMD of −0.44 does not mean that CRP fell by 44%, and it does not predict an individual's blood test result.
What do the marker-specific rankings tell us?
| Marker | Highest-ranked mode | SUCRA ranking metric |
|---|---|---|
| IL-6 | Aerobic training | 84.6% |
| CRP | Resistance training | 89.1% |
| TNF-α | Aerobic training | 97.5% |
SUCRA summarizes a treatment's ranking within the options compared. The 97.5% figure is neither a personal chance of success nor a reduction in inflammation. The review compared aerobic, resistance, combined aerobic-plus-resistance and multicomponent training. Its subgroup analysis put combined training first for IL-6, resistance first for CRP and aerobic first for TNF-α. Different analytical comparisons and participant health groups therefore do not produce a universal winner. A position in a network ranking is also not proof of a meaningful advantage over every alternative.
Should a different first-place result change training?
Our earlier article on exercise dose and inflammatory markers covered a different network of 54 trials, where aerobic work ranked highly for CRP. This 82-study review instead ranked resistance work highest for that marker. Those findings describe different study sets and comparisons; joining them into a single prescription would hide the uncertainty. This review alone gives no reason to abandon aerobic sessions or replace strength training. Nor do the reported rankings establish an optimal weekly duration, number of sets or intensity. A training decision needs an actual training goal, rather than a leaderboard position detached from its outcome.
Most included studies had unclear or high risk of bias, and GRADE certainty was very low for all three markers. Heterogeneity and publication bias further limit confidence. These are exploratory findings in adults aged 60 or older, not evidence about recovery speed in young trained lifters or a demonstrated treatment effect on disease.
What belongs beside a fairlift strength score?
- Write down the training objective first. Improving Big 3 strength and changing an inflammatory blood marker are distinct outcomes.
- Keep a separate workout log for each mode: exercise, load and repetitions for resistance sessions; activity and duration for aerobic sessions. Do not turn a research ranking into a target dose.
- Compare Big 3 records and the fairlift muscle index under consistent recording rules. Do not label a higher strength score as evidence of lower inflammation.
The fairlift muscle index describes relative strength. It does not measure blood markers or assess inflammation. The useful editorial takeaway is to keep the work you actually perform visible and evaluate it against the outcome you intended to train. A stronger squat can answer a strength question; it cannot settle whether CRP changed. Separating those questions preserves the value of both aerobic and resistance training without assigning an unmeasured health effect to a lifting record.
Frequently asked questions
Which older adult exercise is best for inflammation?
This network analysis ranked aerobic training highest for IL-6 and TNF-α, and resistance training highest for CRP. Very low GRADE certainty for every outcome prevents a firm claim that one mode is superior.
Does a CRP SMD of −0.44 mean a 44% reduction?
No. An SMD of −0.44 is a standardized group difference, not a percentage reduction. The CRP SUCRA value of 89.1% is also a ranking summary, not a reduction in CRP.
Can the fairlift muscle index show inflammation changes?
The muscle index is a relative strength score based on Big 3 records and does not measure inflammatory markers. Keeping separate aerobic and resistance logs still cannot establish a change in blood markers.
Source: PubMed (published )